"sbir phase i large scale propagation of cancer cells using the veravec platform in an automated closed system"
Ended Definitive Contract Awarded Last action
- Contract number
- HHSN261201500064C
- Awardee
-
Angiocrine Bioscience, Inc. UEI F6V8JNZZG6E6
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $189,094
Award facts
- Opportunity
-
- PHS20151 Solicitation number
- A solicitation of the national institutes of health (NIH) and the centers for disease control and prevention (CDC) for small business innovation research (sbir) contract proposals Award Notice · Posted Jul 31, 2014
- Contract value 100% obligated
- $189,094.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 13 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- New York, NY 10065, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $189,094 |
About this award
This is a $189,094.00 Firm Fixed Price contract awarded by the National Cancer Institute, a civilian agency, to Angiocrine Bioscience, Inc., a for-profit organization. The contract is for the "SBIR PHASE I LARGE SCALE PROPAGATION OF CANCER CELLS USING THE VERAVEC PLATFORM IN AN AUTOMATED CLOSED SYSTEM" and was set aside for small businesses. The contract has an ultimate completion date of July 21, 2016 and was awarded on September 22, 2015. This appears to be a Small Business Innovation Research (SBIR) Phase I contract focused on developing a platform for large-scale propagation of cancer cells in an automated closed system.
Quick answers
Who was awarded contract HHSN261201500064C?
HHSN261201500064C was awarded to Angiocrine Bioscience, Inc. by National Cancer Institute (National Institutes of Health) on September 22, 2015.
How much is contract HHSN261201500064C worth?
The government has obligated $189,094 on HHSN261201500064C.
Was contract HHSN261201500064C competed?
The extent of competition for HHSN261201500064C was full and open competition after exclusion of sources. The government received 13 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award